Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use

Temporal course of symptom domain improvement in schizophrenia: individual participant data analysis of six antipsychotic drug trials.

The lancet. Psychiatry·2026

Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.

Psychiatry research·2026

Identifying Transdiagnostic Predictors of Depression across Psychoses: Informing Stratified Antidepressant Treatments.

Psychotherapy and psychosomatics·2026

Ensuring generalizability and clinical utility in mental health care applications: Robust artificial intelligence-based treatment predictions in diverse psychosis populations.

Psychiatry and clinical neurosciences·2025

Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial.

CNS drugs·2025

AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trials.

Psychological medicine·2025

Potential role of PPAR-γ/MCT1-related mechanisms in INT131-mediated protection against chronic stress-induced neurobehavioral dysfunction.

Psychopharmacology·2026

The gut microbiota mediates the antidepressant effects of imipramine: Evidence from fecal microbiota transplantation and prebiotic inulin intervention.

Psychopharmacology·2026

Variation in cocaine responses across genetically diverse mouse strains.

Psychopharmacology·2026

Severity-dependent changes in hippocampal necroptosis markers and neuronal loss in a PTSD-like mouse model: potential involvement of nitric oxide signaling.

Psychopharmacology·2026

Association between aperiodic activity and impulsivity in individuals with methamphetamine use disorder.

Psychopharmacology·2026

The mystic trip: how psychedelic research fell for mysticism.

Psychopharmacology·2026

Para-Coumaric Acid Suppresses Vascular Endothelial Growth Factor-Induced DLL4-NOTCH1 Signaling, Tumor Angiogenesis, and Tumor Growth.

Pulse (Basel, Switzerland)·2026

Exploring DHPM-azole hybrid molecules for antibacterial drug discovery: synthesis and biological assessment.

RSC advances·2026

Clicking acylgermanes: modular access to photoinitiators for visible-light photopolymerization.

Organic chemistry frontiers : an international journal of organic chemistry·2026

Integrated in Silico and in Vitro Bioactivity Profiling of Selected South African Plant Constituents Against Carbohydrate-Metabolizing Enzymes for Type 2 Diabetes Therapy.

Bioinformatics and biology insights·2026

Artemisinin-derived hydrophobic tags: structural modification and structure-activity relationship exploration of HDAC6/1 targeting degraders with potent antileukemic efficacy.

Bioorganic chemistry·2026

Six Undescribed Dibenzocyclooctadiene Lignans With Neuroprotective Effects From Kadsura coccinea Roots.

Chemistry & biodiversity·2026

Related Experiment Videos

Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use

Related Concept Videos

Temporal course of symptom domain improvement in schizophrenia: individual participant data analysis of six antipsychotic drug trials.

Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.

Identifying Transdiagnostic Predictors of Depression across Psychoses: Informing Stratified Antidepressant Treatments.

Ensuring generalizability and clinical utility in mental health care applications: Robust artificial intelligence-based treatment predictions in diverse psychosis populations.

Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial.

AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trials.

Potential role of PPAR-γ/MCT1-related mechanisms in INT131-mediated protection against chronic stress-induced neurobehavioral dysfunction.

The gut microbiota mediates the antidepressant effects of imipramine: Evidence from fecal microbiota transplantation and prebiotic inulin intervention.

Variation in cocaine responses across genetically diverse mouse strains.

Severity-dependent changes in hippocampal necroptosis markers and neuronal loss in a PTSD-like mouse model: potential involvement of nitric oxide signaling.

Association between aperiodic activity and impulsivity in individuals with methamphetamine use disorder.

The mystic trip: how psychedelic research fell for mysticism.

Para-Coumaric Acid Suppresses Vascular Endothelial Growth Factor-Induced DLL4-NOTCH1 Signaling, Tumor Angiogenesis, and Tumor Growth.

Exploring DHPM-azole hybrid molecules for antibacterial drug discovery: synthesis and biological assessment.

Clicking acylgermanes: modular access to photoinitiators for visible-light photopolymerization.

Integrated in Silico and in Vitro Bioactivity Profiling of Selected South African Plant Constituents Against Carbohydrate-Metabolizing Enzymes for Type 2 Diabetes Therapy.

Artemisinin-derived hydrophobic tags: structural modification and structure-activity relationship exploration of HDAC6/1 targeting degraders with potent antileukemic efficacy.

Six Undescribed Dibenzocyclooctadiene Lignans With Neuroprotective Effects From Kadsura coccinea Roots.

Related Experiment Videos

Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use

Related Concept Videos

Related Articles